View Older Stories View More Recent Stories
-
Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Dollarama Inc. (DOL:CN) (DLMAF) PT Lowered to Cdn$37 at BMO Capital
-
Pacira Pharmaceuticals to Present at the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference
-
Pacira Pharmaceuticals to Present at the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference
-
Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference
-
Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference
-
Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference
-
Kevin Connelly Joins BMO Financial Corp. Board of Directors
-
Brown Forman (BF-B) PT Lowered to $52 at BMO Capital
-
Canadian Natural Resources Limited (CNQ:CN) PT Lowered to Cdn$55 at BMO Capital
-
LTC Properties (LTC) PT Lowered to $40 at BMO Capital
-
Laurentian Bank of Canada (LB:CN) (LRCDF) PT Lowered to Cdn$45 at BMO Capital
-
BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
-
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
-
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
-
Aptinyx to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Aptinyx to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Replimune to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Replimune to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Entasis Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Entasis Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City
-
Protagonist Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Lannett To Present At The BMO Capital Markets Prescription For Success Healthcare Conference On December 12
-
Jadestone Energy Inc. Announces Director Share Dealing
-
Jadestone Energy Inc. Announces Director Share Dealing
-
Flywheel Energy Closes On Acquisition of Southwestern Energy Company's Fayetteville Shale Business
-
Sienna Biopharmaceuticals (SNNA) PT Lowered to $17 at BMO Capital
-
Roots Corp. (ROOT:CN) (RROTF) PT Lowered to Cdn$9 at BMO Capital
-
BMO Financial Group Reports Fourth Quarter and Fiscal 2018 Results
-
TIBCO Announces Acquisition of Master Data Management Leader Orchestra Networks
-
UMH Properties, Inc. Renews And Expands Its Existing Unsecured Revolving Credit Agreement
-
Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Boston Scientific to Participate in 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference
-
Life & Banc Split Corp. Completes Treasury Offering
-
BRP Inc. (DOO:CN) (DOOO) PT Lowered to Cdn$65 at BMO Capital
-
BioXcel Therapeutics to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
BMO Positive on Laureate Education (LAUR) as DOJ Closed Inquiry
-
Canada economic growth slows in third-quarter, December rate hike seen off cards
-
Workday (WDAY) PT Raised to $170 at BMO Capital
-
Canadian Imperial Bank of Commerce (CM:CN) PT Lowered to Cdn$130 at BMO Capital
-
Bonterra Energy Corp. (BNE:CN) (BNEFF) PT Lowered to Cdn$10 at BMO Capital
-
Palo Alto Networks (PANW) PT Lowered to $205 at BMO Capital
-
Splunk (SPLK) PT Lowered to $132 at BMO Capital
-
BMO Capital Upgrades Rubicon Minerals Corp. (RMX:CN) (RBYCF) to Outperform
-
BMO Capital Starts Arch Coal (ARCH) at Market Perform
-
Xylem Inc. to present at the BMO Capital Markets 2018 Boston Growth Conference

